Innovation Services, Inc. - The Story Behind Innovasan

Fact Sheet No. 1

Innovation Services, Inc. was incorporated in the State of Tennessee on April 16, 1989.

Innovation Services, Inc. was founded by Ellen B Hubrig, President, and Jeffrey G. Hubrig, Vice President, at the request of the United States Department of Energy; to provide consulting services based on national and international recognition of Jeff Hubrig's subject matter expertise in the applied research and development of thermoset polymer materials. This expertise led to the successful repair of the Tokamak Fusion Test Reactor (TFTR), Princeton Plasma Physics Laboratory, Princeton, New Jersey and established Innovation Services as key technology transfer resource for agencies within the Departments of Energy and Defense.

In 2000, the Company expanded its mission focus by networking science and engineering resources within the Department of Energy National Laboratories and the Department of Defense Laboratories; retained as independent contractors to support client programs within the government, university and private sectors.

By 2003, the Company's client base had extended into the medical industry leading the Company to study the behavior of fluid medical waste streams during suction canister collection and disposal at hospital surgery centers. These studies resulted in two patents granted to Innovation Services in 2006 for the management of constituent components found in fluid waste streams.

Recognizing that fluid medical waste disposal practices were an emerging threat to both public health and the environment; in November 2006 Innovation Services launched its network science and engineering resources to conduct an extensive review of prior patent art and published scientific study for treating medical waste streams.

January 2007, Innovation Services received the DoD STTR Topic Number: A07-T036 Solicitation sponsored by the Telemedicine and Advanced Technologies Research Center (TATRC), U.S. Army Medical Research and Materiel Command (USAMRMC), Ft. Detrick, MD. The Solicitation identified the environmental fate of fluid medical waste streams as a priority program and documented that there was no technology solution or product line currently available that would treat fluid medical waste streams. Innovation Services subsequently requested an audience to present their ongoing research initiative to TATRC.

During this time, Innovation Services contacted the Departments of Health and Environmental Protection in 25 States, the Environmental Protection Agency (EPA) and the Centers for Disease Control (CDC). These Agency responses validated the Company’s concern regarding pharmaceutical products and infectious agents found in medical waste streams and expressed an interest in the proposed waste treatment technology solution being investigated by the Company.

Innovation Services completed its extensive review of known science and found an innovative technology solution for fluid medical waste disposal, resulting in two patent applications being filed on April 9, 2007.

Following joint meetings of April 25 and July 19, 2007, TATRC expressed an interest in the potential that Innovation Services' technology solution represented both novel methodology and a design concept that would meet their mission needs. TATRC subsequently invited Innovation Services to submit a BAA Pre-proposal to conduct "proof of principal" research under the USAMRMC Broad Agency Announcement (BAA) Program.

Innovation Services submitted a pre-proposal entitled "Fluid Medical Waste Pre-Treatment System" which was reviewed, resulting in the invitation dated December 4, 2007 to submit a full proposal to TATRC. The full proposal entitled "Fluid Medical (Biological & Pharmacological) Waste Treatment System (FMWTS)" was submitted on February 28, 2008 by Innovasan Corporation.

The expressions of interest by TATRC coupled with the States and other Federal Agency responses were of strategic importance to Innovation Services. These responses:

  1. ) validated the patent pending applications as a ground-breaking technology solution;
  2. ) ratified the existing threat of fluid medical waste streams to public health and the environment;
  3. ) confirmed the business development potential of dual use applications within both military and civilian medical waste generator market segments.

The decision was made by Ellen Hubrig to establish Innovasan Corporation as a separate corporate entity to pursue research and prototype development. Innovasan Corporation enables Innovation Services to retain its founding corporate charter as a leading provider of technology transfer consulting services.